PharmaVitae 2005: Novo Nordisk Global Analysis

The original one-stop information shop

UK head office: +44 (0) 1494 771930 International answering service: US +1 (508) 861 0401 email:

Industry

Other Reports

PharmaVitae 2005: Novo Nordisk Global Analysis

Report

PharmaVitae 2005: Novo Nordisk Global Analysis is a marketing resource from Datamonitor, a leading provider of online data, analytic and forecasting platforms for key vertical sectors. It helps 5,000 of the world's largest companies profit from better, more timely decisions.

From:

$3800

Overview |

Table of contents |

More publications

Introduction

This analysis examines the current position and future outlook for Novo Nordisk in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Scope

Highlights

Reasons to Purchase

Benchmark Novo Nordisk's performance against key rivals in the ethical pharmaceutical sector
Learn how Novo Nordisk can capitalize on its strong diabetes franchise and expand the range of indications of its hematology product, NovoSeven

PharmaVitae 2005: Novo Nordisk Global Analysis

Report Details:

Publisher:

Datamonitor

Type:

Market Study - October 2005

First Publication Date:

20/10/2005